Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:09 AM
Ignite Modification Date:
2025-12-25 @ 2:09 AM
NCT ID:
NCT00401960
Eligibility Criteria:
Inclusion Criteria:
* Age 18 or over
* Definite Enterococcal endocarditis, as defined by modified Duke criteria
* Able to complete follow-up 3 and 6 weeks following completion of intravenous antibiotic therapy
Exclusion Criteria:
* Pregnancy or breast feeding
* Creatine phosphokinase levels over two times the upper limit of normal
* Renal insufficiency or dialysis requirement.
* Presence of chronic indwelling bloodstream catheters or foreign body devices suspected as primary or secondary sites of enterococcal infection unamenable to removal or replacement
* Inability to discontinue or abstain from use of a HMG CoA reductase inhibitor during the study period.
* Hypersensitivity to any of the study medications.
* Any condition that, in the investigator's opinion, may interfere with protocol compliance including, but not limited to, active substance abuse and/or dementia.
* Prosthetic valve endocarditis
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00401960
Study Brief:
Protocol Section:
NCT00401960